EUVIMEDEUVIMED entdecken
Crossref

ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials

Paige M E Hawkins iD, Max J Bedding, David M Hoi, Isabel K Barter, Chen-Yi Cheung, Stefan H Oehlers, Gregory M Cook iD, Tim Clausen, Warwick J Britton, Richard J Payne iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Paige M E Hawkins und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Bacterial Proteins, Antitubercular Agents, Peptides, Cyclic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: University of Sydney, National Health and Medical Research Council, Health Research Council of New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisBacterial ProteinsAntitubercular AgentsPeptides, CyclicDepsipeptidesBiological ProductsAnimalsMicrobial Sensitivity TestsZebrafishHeat-Shock Proteins

Stichwörter der Autor:innen

ClpC1Mycobacterium tuberculosiscyclic peptidesnatural productsproteolysis

Substanzen

Bacterial ProteinsAntitubercular AgentsPeptides, CyclicDepsipeptidesClpC1 protein, Mycobacterium tuberculosisBiological ProductsHeat-Shock Proteins

Autor:innen und Institutionen

  • School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
  • Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, NSW 2006, Australia.
  • Research Institute of Molecular Pathology (IMP), Dr-Bohr-Gasse 7, 1030 Vienna, Austria.
  • Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, PO Box 56, Dunedin 9054, New Zealand.
  • Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
  • A*STAR Infectious Diseases Laboratories (A*STAR ID Laboratories), Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.

ORCID-Profile: Paige M E Hawkins, Gregory M Cook, Richard J Payne

Förderung

  • University of Sydney
  • National Health and Medical Research Council
  • Health Research Council of New Zealand

Zitieren

APA

Hawkins, P. M. E., Bedding, M. J., Hoi, D. M., Barter, I. K., Cheung, C. Y., Oehlers, S. H., Cook, G. M., Clausen, T., Britton, W. J., & Payne, R. J. (2025). ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00689

Vancouver

Hawkins PME, Bedding MJ, Hoi DM, Barter IK, Cheung CY, Oehlers SH, et al. ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00689

BibTeX
@article{Hawkins2025,
  author = {Hawkins, Paige M E and Bedding, Max J and Hoi, David M and Barter, Isabel K and Cheung, Chen-Yi and Oehlers, Stefan H and Cook, Gregory M and Clausen, Tim and Britton, Warwick J and Payne, Richard J},
  title = {ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00689}
}
Kostenlos starten →